Plante Moran Financial Advisors’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-43
Closed -$2K 970
2021
Q4
$2K Hold
43
﹤0.01% 925
2021
Q3
$3K Hold
43
﹤0.01% 844
2021
Q2
$4K Hold
43
﹤0.01% 826
2021
Q1
$6K Hold
43
﹤0.01% 750
2020
Q4
$5K Sell
43
-88
-67% -$9.85K ﹤0.01% 702
2020
Q3
$15K Buy
131
+88
+205% +$15.2K 0.01% 548
2020
Q2
$9K Buy
+43
New +$10.2K ﹤0.01% 537
2018
Q3
Sell
-3
Closed -$1K 835
2018
Q2
$1K Hold
3
﹤0.01% 778
2018
Q1
$2K Buy
+3
New +$1.89K ﹤0.01% 857

Other funds holding RMTI

Plante Moran Financial Advisors's RMTI Position: Q1 2022 in Review

Plante Moran Financial Advisors sold out of Rockwell Medical (RMTI) in Q1 2022, closing a stake of 43 shares — an estimated $2K sold.

Plante Moran Financial Advisors first reported a position in RMTI in Q1 2018 and held it in 9 quarters. The position peaked at $15K in Q3 2020. 58 funds tracked by Wall St. Rank hold RMTI as of Q1 2022.

  • Plante Moran Financial Advisors reported no remaining Rockwell Medical position as of Q1 2022 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 43 Rockwell Medical shares in Q1 2022, an estimated $2K.
  • Plante Moran Financial Advisors first reported a position in Rockwell Medical in Q1 2018 and held it in 9 quarters.
  • Plante Moran Financial Advisors's Rockwell Medical position peaked at $15K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2022.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2022, filed 6 May 2022.